Agenus Inc news

   Watch this stock
Showing stories 1 - 10 of about 85   

Articles published

AGEN 7.12 +0.75 (11.77%)
price chart
Why Agenus Inc. Shares Are Soaring Today
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.
Agenus Inc. (NASDAQ:AGEN) reported a loss in the first quarter  Inside Trade
Agenus (AGEN) Announces Quarterly Earnings Results  Dakota Financial News
Why It's Not Too Late to Buy Agenus, Inc. Stock
Shares of clinical-stage biopharma Agenus (NASDAQ: AGEN ) have been on fire since the company acquired 4-Antibody in February 2014, allowing it to greatly expand its activities in the burgeoning field of immuno-oncology.
Bullish Movements: Agenus (AGEN), Ironwood Pharmaceuticals, (IRWD ...  Techsonian (press release)
Agenus Inc's (AGEN) CEO Garo Armen on Q1 2015 Results - Earnings Call ...
Good day, ladies and gentlemen. And welcome to the Agenus Q1 Earnings Conference Call. As a reminder, today's conference is being recorded.
Why Shares of Agenus Inc Spiked
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.
Here Is Why Agenus Inc (NASDAQ:AGEN) Is Soaring  Bidness ETC
Where is Agenus Inc. (NASDAQ:AGEN) Headed?  Inside Trade
Why Agenus Inc. Stock Skyrocketed
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.
Agenus Rallies On Brain Cancer Vaccine Results  Bidness Etc
UPDATE 1-Agenus brain cancer vaccine doubles survival rate in study  Reuters
Related articles »  
Agenus Inc. (NASDAQ:AGEN) announced the acquisition of key antibody assets ...
(Business Wire)Agenus Inc. (NASDAQ:AGEN) an immunology company developing innovative treatments for cancers and other diseases, announced the acquisition of key antibody assets of Celexion, LLC, a privately held Cambridge, Mass.
Agenus to Report First Quarter 2015 Financial Results on April 23, 2015 ...  MarketWatch
MLV Pounds the Table on Agenus Inc
MLV analyst Arlinda Lee was out pounding the table on Agenus Inc (NASDAQ:AGEN) Wednesday, reiterating a Buy rating and price target of $9.00, which implies an upside of 71% from current levels.
Agenus Inc. (AGEN) Hits New 52-week High During April 24 Session
Agenus Inc. is also a component of the Russell 2000 Index, which is an invaluable tool for any small-cap investor. Consisting of the smaller 2,000 publicly traded companies of the 3,000 largest companies in America by market cap (which combine to make ...
Agenus Inc. (AGEN) is Trading Higher on Unusual Volume for April 23
Agenus Inc. (AGEN) experienced unusually high volume on Apr. 23, as the stock gained 4.77% to a closing price of $6.37. The stock saw 2.24 million shares trade hands over the course of the day on 7,653 trades.
Why Agenus Inc. Stock Briefly Spiked Higher
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.
Maxim Keeps Agenus (AGEN) at Buy, Comments on HerpV Phase 2 Results  StreetInsider.com (subscription)
UPDATE: Agenus Vaccine Shows Significant Reduction in Viral Burden after ...  Benzinga
Related articles »